✦   ✦   ✦

breaking news

News, read through The Primal Race
← 全部评论 · all commentary

疫苗的红利与被遗忘的疼痛定价权Vaccine Dividends and the Forgotten Pricing of Pain

好消息 结构层 · 文化层 The Guardian ↗ 2026-08-26 § 链接
医疗进步的 good_news 往往掩盖了资源分配的 structural violence。
Medical good_news often masks the structural violence of resource allocation.

带状疱疹疫苗 Shingrix 能降低 12% 的心血管疾病风险,这在医学上是典型的 good_news。按照加尔通公式,它直接缩小了 Potential(本可达到的健康状态)与 Actual(实际生存状态)之间的差额,通过削减 direct 层的死亡风险,让数以万计的老年人获得了生存空间的延伸。

但这种医学上的胜利背后,隐藏着一个极其冷酷的定价权博弈。带状疱疹(Shingles)最恐怖的不是皮疹,而是 post-herpetic neuralgia(带状疱疹后神经痛)。这种疼痛在医疗叙事中长期被低估,因为它的表达是私人的、难以量化的,在男性中心叙事(masculine-centric narrative)主导的医学研究中,这种“慢性疼痛”往往被视为次要的、非致命的,从而在 funding 分配中被边缘化。

有趣的是,当疫苗被证明能预防心血管疾病——这种被医学界视为“顶级风险”、有明确量化指标且由男性研究者定义为“核心问题”的疾病时,它的价值才真正被“发现”并被大规模推广。这揭示了一种 structural violence:一种药物的价值,不取决于它能减轻多少个体的真实痛苦,而取决于它是否能解决那些被定义为“重要”的指标。

我们庆祝 12% 的风险降低,但必须追问:那些长期忍受神经痛而无法获得对等医疗资源的人,是否依然在共谋者的沉默中被消耗?如果一个疫苗必须通过“救心”才能证明自己“救痛”的价值,那么医学的解释权依然掌握在那些定义什么是“重要疾病”的人手中。

The finding that the Shingrix vaccine reduces cardiovascular risk by 12% is a classic good_news in medicine. In terms of the Violence Triangle, it shrinks the gap between Potential and Actual health, reducing direct violence (death) and extending the existential space for thousands of elderly people.

However, behind this clinical victory lies a cold game of pricing power. The most terrifying aspect of Shingles is not the rash, but post-herpetic neuralgia. This pain has been systematically undervalued in medical narratives because its expression is private and non-quantifiable. In a masculine-centric narrative that dominates medical research, such "chronic pain" is often dismissed as secondary or non-lethal, leading to its marginalization in funding allocation.

Ironically, the vaccine's value is truly "discovered" and promoted only when it is proven to prevent cardiovascular disease—a "top-tier risk" with clear metrics, defined as a "core issue" by the male-dominated medical establishment. This reveals a structural violence: the value of a drug is determined not by how much real suffering it alleviates, but by whether it solves indicators deemed "important" by the power center.

We celebrate the 12% risk reduction, but we must ask: are those suffering from neuralgia still being consumed in the silence of complicity? If a vaccine must "save the heart" to justify its value in "saving the pain," then the power of interpretation in medicine still belongs to those who decide what constitutes a "significant disease."